Georgy Sagaradze/LinkedIn
Oct 5, 2025, 05:53
Georgy Sagaradze: A Billion-Dollar In Vitro Fertilization Opportunity?
Georgy Sagaradze, Head of Precision Oncology Division at BostonGene, shared a post on LinkedIn:
“A billion-dollar in vitro fertilization opportunity: time to focus on the male factor?
Historically, male infertility has received less attention in the global infertility challenge. Yet with in vitro fertilization (IVF) achieving success in only about 30% of cases, the paradigm is shifting toward addressing male factors as well. Key drivers include:
- Growing social acceptance of assisted reproduction
- Expanding scientific evidence on the mechanisms of male infertility
- Clinical practice moving from female-centric to both-partner focus
- Rising VC investment in male infertility startups
Today this is a ~$1B niche. But with later maternal age and declining sperm quality worldwide, the opportunities ahead may be substantial.
What’s your view?
I’m ready to contribute and collaborate — who’s in?”

-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now
